RNAi for Therapeutic Market Report

Japan RNAi for Therapeutic Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major Region

  • POSTDATE：Sep 16, 2019
  • PAGES：146
  • REPORT CODE：GMM262030
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report offers an overview of the market trends, drivers, and barriers with respect to the Japan RNAi for Therapeutic market. It also provides a detailed overview of the market of different regions across Hokkaido, Tohoku, Kanto, Chubu, Kinki, Chugoku, Shikoku, Kyushu. The report deep analyzes type and application in Japan RNAi for Therapeutic market. Detailed analysis of key players, along with key growth strategies adopted by RNAi for Therapeutic industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.


    By Player:

    • Sirnaomics

    • Ensysce Biosciences

    • BioSpring

    • Bayer Heathcare

    • Tekmira Pharmaceuticals.

    • Celgene

    • Silence Therapeutics

    • Arrowhead

    • Calando Pharmaceuticals

    • Silenseed Incorporated

    • GeneCopoeia

    • Quark Pharmaceuticals

    • Astellas Pharma

    • Biogazelle

    • Benitec Biopharma

    • Alnylam Pharmaceuticals

    • miRagen Therapeutics Research

    • AstraZeneca

    • Dicerna Pharmaceuticals

    • Celsion Corporation

    • CombiMatrix

    • Roche Innovation Center Copenhagen (formerly Santaris Pharma)

    • Creative Animodel

    • Ascletis Pharmaceuticals


    By Type:

    • siRNA

    • miRNA

    • shRNA


    By End-User:

    • Cancer

    • Cardiovascular

    • HBV

    • Others


    By Region:

    • Hokkaido

    • Tohoku

    • Kanto

    • Chubu

    • Kinki

    • Chugoku

    • Shikoku

    • Kyushu

  • 1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of RNAi for Therapeutic Market

    • 1.3 Market Segment by Type

      • 1.3.1 Japan RNAi for Therapeutic Market Size and Growth Rate of siRNA from 2014 to 2026

      • 1.3.2 Japan RNAi for Therapeutic Market Size and Growth Rate of miRNA from 2014 to 2026

      • 1.3.3 Japan RNAi for Therapeutic Market Size and Growth Rate of shRNA from 2014 to 2026

    • 1.4 Market Segment by Application

      • 1.4.1 Japan RNAi for Therapeutic Market Size and Growth Rate of Cancer from 2014 to 2026

      • 1.4.2 Japan RNAi for Therapeutic Market Size and Growth Rate of Cardiovascular from 2014 to 2026

      • 1.4.3 Japan RNAi for Therapeutic Market Size and Growth Rate of HBV from 2014 to 2026

      • 1.4.4 Japan RNAi for Therapeutic Market Size and Growth Rate of Others from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Hokkaido RNAi for Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Tohoku RNAi for Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Kanto RNAi for Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Chubu RNAi for Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Kinki RNAi for Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Chugoku RNAi for Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Shikoku RNAi for Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Kyushu RNAi for Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026


    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants


    3 Segmentation of RNAi for Therapeutic Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of RNAi for Therapeutic by Major Types

      • 3.4.1 Market Size and Growth Rate of siRNA

      • 3.4.2 Market Size and Growth Rate of miRNA

      • 3.4.3 Market Size and Growth Rate of shRNA

    4 Segmentation of RNAi for Therapeutic Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of RNAi for Therapeutic by Major End-Users

      • 4.4.1 Market Size and Growth Rate of RNAi for Therapeutic in Cancer

      • 4.4.2 Market Size and Growth Rate of RNAi for Therapeutic in Cardiovascular

      • 4.4.3 Market Size and Growth Rate of RNAi for Therapeutic in HBV

      • 4.4.4 Market Size and Growth Rate of RNAi for Therapeutic in Others


    5 Market Analysis by Regions

    • 5.1 Japan RNAi for Therapeutic Production Analysis by Regions

    • 5.2 Japan RNAi for Therapeutic Consumption Analysis by Regions


    6 Hokkaido RNAi for Therapeutic Landscape Analysis

    • 6.1 Hokkaido RNAi for Therapeutic Landscape Analysis by Major Types

    • 6.2 Hokkaido RNAi for Therapeutic Landscape Analysis by Major End-Users


    7 Tohoku RNAi for Therapeutic Landscape Analysis

    • 7.1 Tohoku RNAi for Therapeutic Landscape Analysis by Major Types

    • 7.2 Tohoku RNAi for Therapeutic Landscape Analysis by Major End-Users


    8 Kanto RNAi for Therapeutic Landscape Analysis

    • 8.1 Kanto RNAi for Therapeutic Landscape Analysis by Major Types

    • 8.2 Kanto RNAi for Therapeutic Landscape Analysis by Major End-Users


    9 Chubu RNAi for Therapeutic Landscape Analysis

    • 9.1 Chubu RNAi for Therapeutic Landscape Analysis by Major Types

    • 9.2 Chubu RNAi for Therapeutic Landscape Analysis by Major End-Users


    10 Kinki RNAi for Therapeutic Landscape Analysis

    • 10.1 Kinki RNAi for Therapeutic Landscape Analysis by Major Types

    • 10.2 Kinki RNAi for Therapeutic Landscape Analysis by Major End-Users


    11 Chugoku RNAi for Therapeutic Landscape Analysis

    • 11.1 Chugoku RNAi for Therapeutic Landscape Analysis by Major Types

    • 11.2 Chugoku RNAi for Therapeutic Landscape Analysis by Major End-Users


    12 Shikoku RNAi for Therapeutic Landscape Analysis

    • 12.1 Shikoku RNAi for Therapeutic Landscape Analysis by Major Types

    • 12.2 Shikoku RNAi for Therapeutic Landscape Analysis by Major End-Users


    13 Kyushu RNAi for Therapeutic Landscape Analysis

    • 13.1 Kyushu RNAi for Therapeutic Landscape Analysis by Major Types

    • 13.2 Kyushu RNAi for Therapeutic Landscape Analysis by Major End-Users


    14 Major Players Profiles

    • 14.1 Sirnaomics

      • 14.1.1 Sirnaomics Company Profile and Recent Development

      • 14.1.2 Market Performance

      • 14.1.3 Product and Service Introduction

    • 14.2 Ensysce Biosciences

      • 14.2.1 Ensysce Biosciences Company Profile and Recent Development

      • 14.2.2 Market Performance

      • 14.2.3 Product and Service Introduction

    • 14.3 BioSpring

      • 14.3.1 BioSpring Company Profile and Recent Development

      • 14.3.2 Market Performance

      • 14.3.3 Product and Service Introduction

    • 14.4 Bayer Heathcare

      • 14.4.1 Bayer Heathcare Company Profile and Recent Development

      • 14.4.2 Market Performance

      • 14.4.3 Product and Service Introduction

    • 14.5 Tekmira Pharmaceuticals.

      • 14.5.1 Tekmira Pharmaceuticals. Company Profile and Recent Development

      • 14.5.2 Market Performance

      • 14.5.3 Product and Service Introduction

    • 14.6 Celgene

      • 14.6.1 Celgene Company Profile and Recent Development

      • 14.6.2 Market Performance

      • 14.6.3 Product and Service Introduction

    • 14.7 Silence Therapeutics

      • 14.7.1 Silence Therapeutics Company Profile and Recent Development

      • 14.7.2 Market Performance

      • 14.7.3 Product and Service Introduction

    • 14.8 Arrowhead

      • 14.8.1 Arrowhead Company Profile and Recent Development

      • 14.8.2 Market Performance

      • 14.8.3 Product and Service Introduction

    • 14.9 Calando Pharmaceuticals

      • 14.9.1 Calando Pharmaceuticals Company Profile and Recent Development

      • 14.9.2 Market Performance

      • 14.9.3 Product and Service Introduction

    • 14.10 Silenseed Incorporated

      • 14.10.1 Silenseed Incorporated Company Profile and Recent Development

      • 14.10.2 Market Performance

      • 14.10.3 Product and Service Introduction

    • 14.11 GeneCopoeia

      • 14.11.1 GeneCopoeia Company Profile and Recent Development

      • 14.11.2 Market Performance

      • 14.11.3 Product and Service Introduction

    • 14.12 Quark Pharmaceuticals

      • 14.12.1 Quark Pharmaceuticals Company Profile and Recent Development

      • 14.12.2 Market Performance

      • 14.12.3 Product and Service Introduction

    • 14.13 Astellas Pharma

      • 14.13.1 Astellas Pharma Company Profile and Recent Development

      • 14.13.2 Market Performance

      • 14.13.3 Product and Service Introduction

    • 14.14 Biogazelle

      • 14.14.1 Biogazelle Company Profile and Recent Development

      • 14.14.2 Market Performance

      • 14.14.3 Product and Service Introduction

    • 14.15 Benitec Biopharma

      • 14.15.1 Benitec Biopharma Company Profile and Recent Development

      • 14.15.2 Market Performance

      • 14.15.3 Product and Service Introduction

    • 14.16 Alnylam Pharmaceuticals

      • 14.16.1 Alnylam Pharmaceuticals Company Profile and Recent Development

      • 14.16.2 Market Performance

      • 14.16.3 Product and Service Introduction

    • 14.17 miRagen Therapeutics Research

      • 14.17.1 miRagen Therapeutics Research Company Profile and Recent Development

      • 14.17.2 Market Performance

      • 14.17.3 Product and Service Introduction

    • 14.18 AstraZeneca

      • 14.18.1 AstraZeneca Company Profile and Recent Development

      • 14.18.2 Market Performance

      • 14.18.3 Product and Service Introduction

    • 14.19 Dicerna Pharmaceuticals

      • 14.19.1 Dicerna Pharmaceuticals Company Profile and Recent Development

      • 14.19.2 Market Performance

      • 14.19.3 Product and Service Introduction

    • 14.20 Celsion Corporation

      • 14.20.1 Celsion Corporation Company Profile and Recent Development

      • 14.20.2 Market Performance

      • 14.20.3 Product and Service Introduction

    • 14.21 CombiMatrix

      • 14.21.1 CombiMatrix Company Profile and Recent Development

      • 14.21.2 Market Performance

      • 14.21.3 Product and Service Introduction

    • 14.22 Roche Innovation Center Copenhagen (formerly Santaris Pharma)

      • 14.22.1 Roche Innovation Center Copenhagen (formerly Santaris Pharma) Company Profile and Recent Development

      • 14.22.2 Market Performance

      • 14.22.3 Product and Service Introduction

    • 14.23 Creative Animodel

      • 14.23.1 Creative Animodel Company Profile and Recent Development

      • 14.23.2 Market Performance

      • 14.23.3 Product and Service Introduction

    • 14.24 Ascletis Pharmaceuticals

      • 14.24.1 Ascletis Pharmaceuticals Company Profile and Recent Development

      • 14.24.2 Market Performance

      • 14.24.3 Product and Service Introduction

     

    The List of Tables and Figures (Totals 102 Figures and 185 Tables)

     

    • Figure Japan RNAi for Therapeutic Market Size and Growth Rate of siRNA from 2014 to 2026

    • Figure Japan RNAi for Therapeutic Market Size and Growth Rate of miRNA from 2014 to 2026

    • Figure Japan RNAi for Therapeutic Market Size and Growth Rate of shRNA from 2014 to 2026

    • Figure Market Share by Type in 2014

    • Figure Market Share by Type in 2018

    • Figure Market Share by Type in 2026

    • Figure Japan RNAi for Therapeutic Market Size and Growth Rate of Cancer from 2014 to 2026

    • Figure Japan RNAi for Therapeutic Market Size and Growth Rate of Cardiovascular from 2014 to 2026

    • Figure Japan RNAi for Therapeutic Market Size and Growth Rate of HBV from 2014 to 2026

    • Figure Japan RNAi for Therapeutic Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Market Share by End-User in 2014

    • Figure Market Share by End-User in 2018

    • Figure Market Share by End-User in 2026

    • Figure Hokkaido RNAi for Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Tohoku RNAi for Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kanto RNAi for Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Chubu RNAi for Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kinki RNAi for Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Chugoku RNAi for Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Shikoku RNAi for Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kyushu RNAi for Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of RNAi for Therapeutic Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2018

    • Figure Market Share of TOP 5 Players in 2018

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of RNAi for Therapeutic

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of RNAi for Therapeutic by Different Types from 2014 to 2026

    • Table Consumption Share of RNAi for Therapeutic by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of siRNA

    • Figure Market Size and Growth Rate of miRNA

    • Figure Market Size and Growth Rate of shRNA

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of RNAi for Therapeutic by Different End-Users from 2014 to 2026

    • Table Consumption Share of RNAi for Therapeutic by Different End-Users from 2014 to 2026

    • Figure Japan RNAi for Therapeutic Market Size and Growth Rate of Cancer from 2014 to 2026

    • Figure Japan RNAi for Therapeutic Market Size and Growth Rate of Cardiovascular from 2014 to 2026

    • Figure Japan RNAi for Therapeutic Market Size and Growth Rate of HBV from 2014 to 2026

    • Figure Japan RNAi for Therapeutic Market Size and Growth Rate of Others from 2014 to 2026

    • Table Japan RNAi for Therapeutic Production by Regions

    • Table Japan RNAi for Therapeutic Production Share by Regions

    • Figure Japan RNAi for Therapeutic Production Share by Regions in 2014

    • Figure Japan RNAi for Therapeutic Production Share by Regions in 2018

    • Figure Japan RNAi for Therapeutic Production Share by Regions in 2026

    • Table Japan RNAi for Therapeutic Consumption by Regions

    • Table Japan RNAi for Therapeutic Consumption Share by Regions

    • Figure Japan RNAi for Therapeutic Consumption Share by Regions in 2014

    • Figure Japan RNAi for Therapeutic Consumption Share by Regions in 2018

    • Figure Japan RNAi for Therapeutic Consumption Share by Regions in 2026

    • Table Hokkaido RNAi for Therapeutic Consumption by Types from 2014 to 2026

    • Table Hokkaido RNAi for Therapeutic Consumption Share by Types from 2014 to 2026

    • Figure Hokkaido RNAi for Therapeutic Consumption Share by Types in 2014

    • Figure Hokkaido RNAi for Therapeutic Consumption Share by Types in 2018

    • Figure Hokkaido RNAi for Therapeutic Consumption Share by Types in 2026

    • Table Hokkaido RNAi for Therapeutic Consumption by End-Users from 2014 to 2026

    • Table Hokkaido RNAi for Therapeutic Consumption Share by End-Users from 2014 to 2026

    • Figure Hokkaido RNAi for Therapeutic Consumption Share by End-Users in 2014

    • Figure Hokkaido RNAi for Therapeutic Consumption Share by End-Users in 2018

    • Figure Hokkaido RNAi for Therapeutic Consumption Share by End-Users in 2026

    • Table Tohoku RNAi for Therapeutic Consumption by Types from 2014 to 2026

    • Table Tohoku RNAi for Therapeutic Consumption Share by Types from 2014 to 2026

    • Figure Tohoku RNAi for Therapeutic Consumption Share by Types in 2014

    • Figure Tohoku RNAi for Therapeutic Consumption Share by Types in 2018

    • Figure Tohoku RNAi for Therapeutic Consumption Share by Types in 2026

    • Table Tohoku RNAi for Therapeutic Consumption by End-Users from 2014 to 2026

    • Table Tohoku RNAi for Therapeutic Consumption Share by End-Users from 2014 to 2026

    • Figure Tohoku RNAi for Therapeutic Consumption Share by End-Users in 2014

    • Figure Tohoku RNAi for Therapeutic Consumption Share by End-Users in 2018

    • Figure Tohoku RNAi for Therapeutic Consumption Share by End-Users in 2026

    • Table Kanto RNAi for Therapeutic Consumption by Types from 2014 to 2026

    • Table Kanto RNAi for Therapeutic Consumption Share by Types from 2014 to 2026

    • Figure Kanto RNAi for Therapeutic Consumption Share by Types in 2014

    • Figure Kanto RNAi for Therapeutic Consumption Share by Types in 2018

    • Figure Kanto RNAi for Therapeutic Consumption Share by Types in 2026

    • Table Kanto RNAi for Therapeutic Consumption by End-Users from 2014 to 2026

    • Table Kanto RNAi for Therapeutic Consumption Share by End-Users from 2014 to 2026

    • Figure Kanto RNAi for Therapeutic Consumption Share by End-Users in 2014

    • Figure Kanto RNAi for Therapeutic Consumption Share by End-Users in 2018

    • Figure Kanto RNAi for Therapeutic Consumption Share by End-Users in 2026

    • Table Chubu RNAi for Therapeutic Consumption by Types from 2014 to 2026

    • Table Chubu RNAi for Therapeutic Consumption Share by Types from 2014 to 2026

    • Figure Chubu RNAi for Therapeutic Consumption Share by Types in 2014

    • Figure Chubu RNAi for Therapeutic Consumption Share by Types in 2018

    • Figure Chubu RNAi for Therapeutic Consumption Share by Types in 2026

    • Table Chubu RNAi for Therapeutic Consumption by End-Users from 2014 to 2026

    • Table Chubu RNAi for Therapeutic Consumption Share by End-Users from 2014 to 2026

    • Figure Chubu RNAi for Therapeutic Consumption Share by End-Users in 2014

    • Figure Chubu RNAi for Therapeutic Consumption Share by End-Users in 2018

    • Figure Chubu RNAi for Therapeutic Consumption Share by End-Users in 2026

    • Table Kinki RNAi for Therapeutic Consumption by Types from 2014 to 2026

    • Table Kinki RNAi for Therapeutic Consumption Share by Types from 2014 to 2026

    • Figure Kinki RNAi for Therapeutic Consumption Share by Types in 2014

    • Figure Kinki RNAi for Therapeutic Consumption Share by Types in 2018

    • Figure Kinki RNAi for Therapeutic Consumption Share by Types in 2026

    • Table Kinki RNAi for Therapeutic Consumption by End-Users from 2014 to 2026

    • Table Kinki RNAi for Therapeutic Consumption Share by End-Users from 2014 to 2026

    • Figure Kinki RNAi for Therapeutic Consumption Share by End-Users in 2014

    • Figure Kinki RNAi for Therapeutic Consumption Share by End-Users in 2018

    • Figure Kinki RNAi for Therapeutic Consumption Share by End-Users in 2026

    • Table Chugoku RNAi for Therapeutic Consumption by Types from 2014 to 2026

    • Table Chugoku RNAi for Therapeutic Consumption Share by Types from 2014 to 2026

    • Figure Chugoku RNAi for Therapeutic Consumption Share by Types in 2014

    • Figure Chugoku RNAi for Therapeutic Consumption Share by Types in 2018

    • Figure Chugoku RNAi for Therapeutic Consumption Share by Types in 2026

    • Table Chugoku RNAi for Therapeutic Consumption by End-Users from 2014 to 2026

    • Table Chugoku RNAi for Therapeutic Consumption Share by End-Users from 2014 to 2026

    • Figure Chugoku RNAi for Therapeutic Consumption Share by End-Users in 2014

    • Figure Chugoku RNAi for Therapeutic Consumption Share by End-Users in 2018

    • Figure Chugoku RNAi for Therapeutic Consumption Share by End-Users in 2026

    • Table Shikoku RNAi for Therapeutic Consumption by Types from 2014 to 2026

    • Table Shikoku RNAi for Therapeutic Consumption Share by Types from 2014 to 2026

    • Figure Shikoku RNAi for Therapeutic Consumption Share by Types in 2014

    • Figure Shikoku RNAi for Therapeutic Consumption Share by Types in 2018

    • Figure Shikoku RNAi for Therapeutic Consumption Share by Types in 2026

    • Table Shikoku RNAi for Therapeutic Consumption by End-Users from 2014 to 2026

    • Table Shikoku RNAi for Therapeutic Consumption Share by End-Users from 2014 to 2026

    • Figure Shikoku RNAi for Therapeutic Consumption Share by End-Users in 2014

    • Figure Shikoku RNAi for Therapeutic Consumption Share by End-Users in 2018

    • Figure Shikoku RNAi for Therapeutic Consumption Share by End-Users in 2026

    • Table Kyushu RNAi for Therapeutic Consumption by Types from 2014 to 2026

    • Table Kyushu RNAi for Therapeutic Consumption Share by Types from 2014 to 2026

    • Figure Kyushu RNAi for Therapeutic Consumption Share by Types in 2014

    • Figure Kyushu RNAi for Therapeutic Consumption Share by Types in 2018

    • Figure Kyushu RNAi for Therapeutic Consumption Share by Types in 2026

    • Table Kyushu RNAi for Therapeutic Consumption by End-Users from 2014 to 2026

    • Table Kyushu RNAi for Therapeutic Consumption Share by End-Users from 2014 to 2026

    • Figure Kyushu RNAi for Therapeutic Consumption Share by End-Users in 2014

    • Figure Kyushu RNAi for Therapeutic Consumption Share by End-Users in 2018

    • Figure Kyushu RNAi for Therapeutic Consumption Share by End-Users in 2026

    • Table Company Profile and Development Status of Sirnaomics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sirnaomics

    • Figure Sales and Growth Rate Analysis of Sirnaomics

    • Figure Revenue and Market Share Analysis of Sirnaomics

    • Table Product and Service Introduction of Sirnaomics

    • Table Company Profile and Development Status of Ensysce Biosciences

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ensysce Biosciences

    • Figure Sales and Growth Rate Analysis of Ensysce Biosciences

    • Figure Revenue and Market Share Analysis of Ensysce Biosciences

    • Table Product and Service Introduction of Ensysce Biosciences

    • Table Company Profile and Development Status of BioSpring

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of BioSpring

    • Figure Sales and Growth Rate Analysis of BioSpring

    • Figure Revenue and Market Share Analysis of BioSpring

    • Table Product and Service Introduction of BioSpring

    • Table Company Profile and Development Status of Bayer Heathcare

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer Heathcare

    • Figure Sales and Growth Rate Analysis of Bayer Heathcare

    • Figure Revenue and Market Share Analysis of Bayer Heathcare

    • Table Product and Service Introduction of Bayer Heathcare

    • Table Company Profile and Development Status of Tekmira Pharmaceuticals.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Tekmira Pharmaceuticals.

    • Figure Sales and Growth Rate Analysis of Tekmira Pharmaceuticals.

    • Figure Revenue and Market Share Analysis of Tekmira Pharmaceuticals.

    • Table Product and Service Introduction of Tekmira Pharmaceuticals.

    • Table Company Profile and Development Status of Celgene

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Celgene

    • Figure Sales and Growth Rate Analysis of Celgene

    • Figure Revenue and Market Share Analysis of Celgene

    • Table Product and Service Introduction of Celgene

    • Table Company Profile and Development Status of Silence Therapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Silence Therapeutics

    • Figure Sales and Growth Rate Analysis of Silence Therapeutics

    • Figure Revenue and Market Share Analysis of Silence Therapeutics

    • Table Product and Service Introduction of Silence Therapeutics

    • Table Company Profile and Development Status of Arrowhead

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Arrowhead

    • Figure Sales and Growth Rate Analysis of Arrowhead

    • Figure Revenue and Market Share Analysis of Arrowhead

    • Table Product and Service Introduction of Arrowhead

    • Table Company Profile and Development Status of Calando Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Calando Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Calando Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Calando Pharmaceuticals

    • Table Product and Service Introduction of Calando Pharmaceuticals

    • Table Company Profile and Development Status of Silenseed Incorporated

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Silenseed Incorporated

    • Figure Sales and Growth Rate Analysis of Silenseed Incorporated

    • Figure Revenue and Market Share Analysis of Silenseed Incorporated

    • Table Product and Service Introduction of Silenseed Incorporated

    • Table Company Profile and Development Status of GeneCopoeia

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GeneCopoeia

    • Figure Sales and Growth Rate Analysis of GeneCopoeia

    • Figure Revenue and Market Share Analysis of GeneCopoeia

    • Table Product and Service Introduction of GeneCopoeia

    • Table Company Profile and Development Status of Quark Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Quark Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Quark Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Quark Pharmaceuticals

    • Table Product and Service Introduction of Quark Pharmaceuticals

    • Table Company Profile and Development Status of Astellas Pharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Astellas Pharma

    • Figure Sales and Growth Rate Analysis of Astellas Pharma

    • Figure Revenue and Market Share Analysis of Astellas Pharma

    • Table Product and Service Introduction of Astellas Pharma

    • Table Company Profile and Development Status of Biogazelle

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biogazelle

    • Figure Sales and Growth Rate Analysis of Biogazelle

    • Figure Revenue and Market Share Analysis of Biogazelle

    • Table Product and Service Introduction of Biogazelle

    • Table Company Profile and Development Status of Benitec Biopharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Benitec Biopharma

    • Figure Sales and Growth Rate Analysis of Benitec Biopharma

    • Figure Revenue and Market Share Analysis of Benitec Biopharma

    • Table Product and Service Introduction of Benitec Biopharma

    • Table Company Profile and Development Status of Alnylam Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Alnylam Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Alnylam Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Alnylam Pharmaceuticals

    • Table Product and Service Introduction of Alnylam Pharmaceuticals

    • Table Company Profile and Development Status of miRagen Therapeutics Research

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of miRagen Therapeutics Research

    • Figure Sales and Growth Rate Analysis of miRagen Therapeutics Research

    • Figure Revenue and Market Share Analysis of miRagen Therapeutics Research

    • Table Product and Service Introduction of miRagen Therapeutics Research

    • Table Company Profile and Development Status of AstraZeneca

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca

    • Figure Sales and Growth Rate Analysis of AstraZeneca

    • Figure Revenue and Market Share Analysis of AstraZeneca

    • Table Product and Service Introduction of AstraZeneca

    • Table Company Profile and Development Status of Dicerna Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Dicerna Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Dicerna Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Dicerna Pharmaceuticals

    • Table Product and Service Introduction of Dicerna Pharmaceuticals

    • Table Company Profile and Development Status of Celsion Corporation

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Celsion Corporation

    • Figure Sales and Growth Rate Analysis of Celsion Corporation

    • Figure Revenue and Market Share Analysis of Celsion Corporation

    • Table Product and Service Introduction of Celsion Corporation

    • Table Company Profile and Development Status of CombiMatrix

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of CombiMatrix

    • Figure Sales and Growth Rate Analysis of CombiMatrix

    • Figure Revenue and Market Share Analysis of CombiMatrix

    • Table Product and Service Introduction of CombiMatrix

    • Table Company Profile and Development Status of Roche Innovation Center Copenhagen (formerly Santaris Pharma)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Roche Innovation Center Copenhagen (formerly Santaris Pharma)

    • Figure Sales and Growth Rate Analysis of Roche Innovation Center Copenhagen (formerly Santaris Pharma)

    • Figure Revenue and Market Share Analysis of Roche Innovation Center Copenhagen (formerly Santaris Pharma)

    • Table Product and Service Introduction of Roche Innovation Center Copenhagen (formerly Santaris Pharma)

    • Table Company Profile and Development Status of Creative Animodel

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Creative Animodel

    • Figure Sales and Growth Rate Analysis of Creative Animodel

    • Figure Revenue and Market Share Analysis of Creative Animodel

    • Table Product and Service Introduction of Creative Animodel

    • Table Company Profile and Development Status of Ascletis Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ascletis Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Ascletis Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Ascletis Pharmaceuticals

    • Table Product and Service Introduction of Ascletis Pharmaceuticals

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US